CD8+ T cell differentiation into NK-like effector cells drives transplant rejection

Read full text
Authors: Dawei Zou, Stephanie G. Yi, Yulin Dai, Luan D. Truong, Lillian W. Gaber, Richard L. Knight, Xiang Xiao, Rafik M. Ghobrial, Xian C. Li, Zhongming Zhao, Wenhao Chen, A.Osama Gaber
Cited by: 2
References: 47

Abstract

T cells are central drivers of transplant rejection, yet the differentiation fates underlying this process remain unclear. Using single-cell transcriptomic profiling of human kidney allograft biopsies, we identified a predominant infiltrating CD8 + T cell subset exhibiting killer cell lectin-like receptor (KLR) + NK-like features. Mechanistic studies in mice showed that the KLR + subset emerged de novo post-transplantation and dominated the CD8 + T cell infiltrate in rejecting allografts. These NK-like CD8 + T cells expressed high levels of interferon regulatory factor 4 (IRF4), and Irf4 deletion disrupted their differentiation and induced transplant acceptance. Therapeutically, either costimulation blockade or mTOR inhibition substantially reduced the generation of NK-like CD8 + T cells; however, the persistence of these cells ultimately led to rejection. Notably, combining costimulation blockade with mTOR inhibition completely abrogated their generation and enabled transplant acceptance. Together, these findings identify KLR + NK-like CD8 + T cells as key mediators of transplant rejection, highlighting the need for more effective strategies to block their differentiation and improve transplant outcomes.

Fields of Study & Subjects

Immune Cell Function and Interaction T-cell and B-cell Immunology Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Molecular Therapy
Publisher
Elsevier BV
Volume
34
Issue
5
Pages
2709–2724
Publication date
21 January 2026
Language
EN